Suzhou Sepax Technologies
688758
Juneway Electronic Technology
301458
Jiujiang Defu Technology
301511
Cubic Digital Technology
300344
Ningbo Shuanglin Auto Parts
300100
CN Stock MarketDetailed Quotes
300111 Zhejiang Sunflower Great Health
- 3.06
- -0.08-2.55%
Market Closed Jan 10 15:00 CST
3.94BMarket Cap113.33P/E (TTM)
3.26High3.05Low286.75KlotVolume3.15Open3.14Pre Close90.06MTurnover2.23%Turnover Ratio180.00P/E (Static)1.29BShares4.0752wk High5.78P/B3.94BFloat Cap1.8352wk Low3.77Limit Up1.29BShs Float13.23Historical High2.51Limit Down6.69%Amplitude1.82Historical Low--Dividend TTM3.14Avg Price151.78KlotAsk--Div YieldTTM100Lot Size124.43KlotBid
Zhejiang Sunflower Great Health News
Zhejiang Sunflower Great Health's Chairman Resigns Early; Shares Up 5%
Zhejiang Sunflower Great Health (300111.SZ) chairman Cao Yang resigns.
Zhejiang sunflower great health (300111.SZ) announced that the board of directors recently received the resignation of Mr. Cao Yang, the company's chairman.
Express News | Analysis institutions APK-Inform: It is expected that the sunflower seed production in Ukraine will increase by 6-8% in 2025, thanks to a possible 5% increase in planting area.
Sunflower: Third quarter report 2024
Zhejiang Sunflower Great Health (300111.SZ) released its performance for the first three quarters, with a net income of 2.7852 million yuan, a year-on-year decrease of 88.36%.
Zhejiang Sunflower Great Health (300111.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters reaching 2.2...
Zhejiang Sunflower Great Health Unit's Hypertension Drug Up for Fujian's Centralized Bulk Purchase List
Zhejiang Sunflower Great Health (300111.SZ) subsidiary Baida Pharmaceutical Losartan Dispersible Tablets is planned to be selected for the pharmaceutical centralized procurement in Fujian Province.
zhejiang sunflower great health (300111.SZ) announcement, the company's subsidiary zhejiang beida pharmaceutical co., ltd. (referred to as "beida pharmaceutical"...
Express News | Zhejiang Sunflower Great Health: Subsidiaries are planning to be selected for the fifth batch of centralized drug procurement in Fujian Province.
Zhejiang Sunflower Great Health (300111.SZ): 0.167 billion restricted shares will be unlocked on September 18th.
Geelong on September 11th announced a notice about the lifting of the restricted shares of stocks issued to specific entities. The restricted shares being lifted this time are the stocks issued to specific entities, with a quantity of 0.167 billion shares, accounting for 13.01% of the company's current total share capital. The restricted shares will be listed for trading on September 18, 2024 (Wednesday).
Sunflowers: 2024 Semi-Annual Report
Sunflower: 2024 Semi-Annual Report Summary
Express News | Zhejiang sunflower great health: the net income in the first half of the year was 1.8045 million yuan, turning a profit year-on-year.
Zhejiang Sunflower Great Health (300111.SZ): The net income in the first half of the year was 1.8045 million yuan, turning around from a loss on a year-on-year basis.
On August 28, Great Health (300111.SZ) released its semi-annual report for 2024, with a revenue of 0.158 billion yuan, a year-on-year increase of 4.80%; a net income of 1.8045 million yuan attributable to the company's shareholders, turning losses into profits year-on-year; a net income of 0.8093 million yuan attributable to the company's shareholders after deducting non-recurring gains and losses; and an earnings per share of 0.001 yuan.
Zhejiang Sunflower (300111.SZ) released its semi-annual performance with a net income of 1.8045 million yuan, which turned a loss into a profit on a year-on-year basis.
Zhejiang Sunflower Great Health (300111.SZ) disclosed its 2024 interim report, achieving revenue of...
Express News | Dealers: India's palm oil imports in May increased by 12.4% on a month-on-month basis, reaching 769,000 tons, the highest level in four months. India's soybean oil imports in May fell by 16.5% on a month-on-month basis to 322,000 tons. India's May sunflow
Sunflower (300111.SZ): Net profit of 551,000 yuan for the first quarter reversed the year-on-year loss
Gelonghui, April 26 | Sunflower (300111.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 83.6929 million yuan, up 36.57% year on year; net profit attributable to shareholders of listed companies was 551,000 yuan, which turned a year-on-year loss into a profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 4391,000 yuan; basic earnings per share were 0.0004 yuan.
Express News | Sunflower: Subsidiaries participate in centralized drug procurement selection
Sunflower (300111.SZ) announced its 2023 annual results, turning a loss into a profit of 21.7479 million yuan
Sunflower (300111.SZ) released its 2023 annual report. The company's revenue was 338 million yuan,...
Express News | Shenglan Co., Ltd. and others set up energy technology companies including AI industry application system integration business
Aiskai (300521.SZ) shareholders added Orange Qiandao No. 1 Fund and Yanfeng Sunflower No. 1 Fund reduced their holdings by only 200 shares
Ascay (300521.SZ) announced that the company received “...” from the Tiancheng Qiandao No. 1 Fund and the Yanfeng Sunflower No. 1 Fund